• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DTX3L 通过泛素化 cGAS 抑制胰腺癌中的抗肿瘤免疫。

DTX3L mediated ubiquitination of cGAS suppresses antitumor immunity in pancreatic cancer.

机构信息

Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Putian University, Putian, 351100, Fujian, China.

出版信息

Biochem Biophys Res Commun. 2023 Nov 12;681:106-110. doi: 10.1016/j.bbrc.2023.09.073. Epub 2023 Sep 25.

DOI:10.1016/j.bbrc.2023.09.073
PMID:37774567
Abstract

The global incidence of pancreatic cancer is associated with a high mortality rate and one of the lowest survival rates among all types of cancer. The clinical management modalities for pancreatic cancer encompass surgical intervention, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination thereof. Nevertheless, the diagnosis of pancreatic cancer often occurs at an advanced stage, thereby restricting treatment options and diminishing the prospects of achieving a cure. The cGAS-STING pathway has emerged as a potential target for antitumor therapy due to its role in promoting immune responses against cancer cells. Activation of the cGAS-STING pathway in tumor cells can lead to the production of pro-inflammatory cytokines and type I interferons, which can enhance the recruitment and activation of immune cells to the tumor microenvironment. The cGAS protein was detected in only a half of tumor tissues in pancreatic cancer patients and the underlying mechanism is still elusive. In this study, we have identified the E3 ligase DTX3L as a key regulator of cGAS-STING signaling in pancreatic cancer cells by mediating the ubiquitination and degradation of cGAS. The expression levels of DTX3L were found to be upregulated in pancreatic tumor tissues and correlated with a poor prognosis for patients with pancreatic cancer. Silencing of DTX3L resulted in enhanced activation of the cGAS-STING signaling pathway and improved antitumor immunity for pancreatic cancer, suggesting that targeting the DTX3L-cGAS axis could hold promise for the treatment of this disease.

摘要

全球范围内胰腺癌的发病率与高死亡率相关,并且是所有癌症类型中存活率最低的癌症之一。胰腺癌的临床治疗方式包括手术干预、化疗、放疗、靶向治疗、免疫治疗或联合治疗。然而,胰腺癌的诊断往往发生在晚期,从而限制了治疗选择并降低了治愈的可能性。cGAS-STING 通路已成为抗肿瘤治疗的潜在靶点,因为它在促进针对癌细胞的免疫反应方面发挥作用。肿瘤细胞中 cGAS-STING 通路的激活可导致促炎细胞因子和 I 型干扰素的产生,从而增强免疫细胞向肿瘤微环境的募集和激活。在胰腺癌患者的肿瘤组织中仅检测到一半的 cGAS 蛋白,其潜在机制仍不清楚。在这项研究中,我们通过介导 cGAS 的泛素化和降解,确定了 E3 连接酶 DTX3L 是胰腺癌细胞中 cGAS-STING 信号的关键调节剂。发现 DTX3L 的表达水平在胰腺肿瘤组织中上调,并与胰腺癌患者的预后不良相关。沉默 DTX3L 可增强 cGAS-STING 信号通路的激活并改善胰腺癌的抗肿瘤免疫,表明靶向 DTX3L-cGAS 轴可能为治疗这种疾病提供希望。

相似文献

1
DTX3L mediated ubiquitination of cGAS suppresses antitumor immunity in pancreatic cancer.DTX3L 通过泛素化 cGAS 抑制胰腺癌中的抗肿瘤免疫。
Biochem Biophys Res Commun. 2023 Nov 12;681:106-110. doi: 10.1016/j.bbrc.2023.09.073. Epub 2023 Sep 25.
2
DTX3L Accelerates Pancreatic cancer Progression via FAK/PI3K/AKT Axis.DTX3L通过FAK/PI3K/AKT轴加速胰腺癌进展。
Biochem Genet. 2024 Apr;62(2):814-830. doi: 10.1007/s10528-023-10451-4. Epub 2023 Jul 17.
3
Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC.高压氧促进依托泊苷诱导的 cGAS-STING 激活,增强 PD-1 抗体在 HCC 中的抗肿瘤疗效。
J Immunother Cancer. 2022 Aug;10(8). doi: 10.1136/jitc-2021-004006.
4
Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.环状鸟苷酸-干扰素基因刺激物信号轴在癌症发生发展和免疫治疗中的全面阐述。
Mol Cancer. 2020 Aug 27;19(1):133. doi: 10.1186/s12943-020-01250-1.
5
Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.放射治疗通过cGAS-STING激活诱导的PD-L1上调促进肝细胞癌免疫逃逸。
Int J Radiat Oncol Biol Phys. 2022 Apr 1;112(5):1243-1255. doi: 10.1016/j.ijrobp.2021.12.162. Epub 2022 Jan 2.
6
The Function of cGAS-STING Pathway in Treatment of Pancreatic Cancer.cGAS-STING 通路在胰腺癌治疗中的作用。
Front Immunol. 2021 Nov 9;12:781032. doi: 10.3389/fimmu.2021.781032. eCollection 2021.
7
Simultaneous Activation of Pyroptosis and cGAS-STING Pathway with Epigenetic/ Photodynamic Nanotheranostic for Enhanced Tumor Photoimmunotherapy.利用表观遗传/光动力纳米诊疗技术同时激活细胞焦亡和cGAS-STING通路以增强肿瘤光免疫治疗
Adv Mater. 2024 Feb;36(7):e2306419. doi: 10.1002/adma.202306419. Epub 2023 Dec 7.
8
cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer.cGAS-STING 信号通路促进免疫细胞克服胰腺癌中的成纤维细胞障碍。
Sci Rep. 2022 Jun 30;12(1):10466. doi: 10.1038/s41598-022-14297-5.
9
DTX3L Enhances Type I Interferon Antiviral Response by Promoting the Ubiquitination and Phosphorylation of TBK1.DTX3L 通过促进 TBK1 的泛素化和磷酸化增强 I 型干扰素抗病毒反应。
J Virol. 2023 Jun 29;97(6):e0068723. doi: 10.1128/jvi.00687-23. Epub 2023 May 31.
10
The paradoxical role of radiation-induced cGAS-STING signalling network in tumour immunity.辐射诱导的cGAS-STING信号网络在肿瘤免疫中的矛盾作用。
Immunology. 2023 Mar;168(3):375-388. doi: 10.1111/imm.13592. Epub 2022 Oct 25.

引用本文的文献

1
The role of cGAS-STING pathway ubiquitination in innate immunity and multiple diseases.环鸟苷酸-腺苷酸合成酶-干扰素基因刺激蛋白(cGAS-STING)通路泛素化在固有免疫及多种疾病中的作用
Front Immunol. 2025 Feb 14;16:1522200. doi: 10.3389/fimmu.2025.1522200. eCollection 2025.
2
Targeting protein modification: a new direction for immunotherapy of pancreatic cancer.靶向蛋白质修饰:胰腺癌免疫治疗的新方向。
Int J Biol Sci. 2025 Jan 1;21(1):63-74. doi: 10.7150/ijbs.101861. eCollection 2025.
3
cGAS/STING pathway and gastrointestinal cancer: Mechanisms and diagnostic and therapeutic targets (Review).
cGAS/STING 通路与胃肠道肿瘤:机制及诊断与治疗靶点(综述)。
Oncol Rep. 2025 Jan;53(1). doi: 10.3892/or.2024.8848. Epub 2024 Nov 29.
4
Expression, potential biological behaviour and clinical significance of MCM3 in pancreatic adenocarcinoma: a comprehensive study integrating high throughput sequencing, CRISPR screening and in-house immunohistochemistry.MCM3 在胰腺腺癌中的表达、潜在生物学行为和临床意义:整合高通量测序、CRISPR 筛选和内部免疫组织化学的综合研究。
Ann Med. 2024 Dec;56(1):2405879. doi: 10.1080/07853890.2024.2405879. Epub 2024 Sep 23.